Furthermore, existing evidence highlights the involvement of miRNA-containing EVs in the angiogenesis of ovarian cancer by indicating the contribution of miR-141-3p-carrying EVs in the angiogenesis of endothelial cells in ovarian cancer via the activation of the JAK/STAT3 and NF-κB pathway [39]. This evidence concerns the gene STAT3 and ovarian carcinoma.